Steven Erly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steven Erly has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Jennifer R. Reuer
Washington State Department of Health, Olympia, WA, USA
3 shared publicationsJulia C. Dombrowski
Public Health Seattle & King County, HIV/STI/HCV Program, Seattle, USA
3 shared publicationsMonisha Sharma
Department of Global Health, University of Washington, Seattle, WA, USA
3 shared publicationsAnjum Hajat
Affiliation Department of Epidemiology, University of Washington, Seattle, Washington, United States of America
2 shared publicationsChristine M. Khosropour
Affiliation Department of Epidemiology, University of Washington, Seattle, Washington, United States of America
2 shared publicationsRachel M. Amiya
Office of Infectious Disease, Washington State Department of Health, Tumwater, USA
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Elsevier in AJPM Focus
- Vol. 5 (6)
Increases in Overdose Deaths Among People With HIV Across 14 U.S. Jurisdictions, 2014–2023
- 12 August 2026
- Published by Elsevier in AJPM Focus
- Vol. 5 (6)
Open AccessIncreases in Overdose Deaths Among People With HIV Across 14 U.S. Jurisdictions, 2014–2023
- Open Access
- 11 July 2026
- Published by Elsevier in SSRN Electronic Journal
Association Between Mpox Vaccination and Disease Severity Over Time in Washington State, 2023-2025
Background: Previous studies suggest that mpox vaccination reduces disease severity among breakthrough infections, but these studies relied on unadjusted comparisons without accounting for confounding by age or health status. We compared disease severity between vaccinated and unvaccinated mpox cases after adjusting for potential confounders. We also evaluated whether time since vaccination was associated with mpox disease severity.Methods: We conducted a retrospective analysis of all confirmed and probable mpox cases reported in Washington State from January 1, 2023 to June 30, 2025, using state surveillance data supplemented by medical record abstraction. Disease severity was measured using an adapted Mpox Severity Scoring System. Individuals were classified as vaccinated if they received at least one dose of the MVA-BN vaccine at least 14 days before symptom onset. Linear regression was used to estimate the associations between vaccination status and disease severity, adjusting for age and immunocompromising conditions. Among vaccinated individuals, we used linear regression to examine associations between time since last vaccine dose (<12 months, 12-<24 months, 24+ months) and disease severity.Findings: Of the 175 reported mpox cases, 164 cases met inclusion criteria; 94 (57%) were vaccinated and 70 (43%) were unvaccinated. The mean mpox severity score among vaccinated individuals was 4·6 (95% CI 4·3-4·9). Vaccination was associated with a 1·44-point lower severity score (0·79-2·09, p<0·001), and with a 1·48-point lower score after adjusting (0·77-2·19, p24 months prior to infection had a 0·97-point higher severity score than those vaccinated within the previous year (0·07-1·87, p=0·035). After adjusting, the difference was 0·93 points (-0·12-1·98, p=0·082).Interpretation: Mpox vaccination was associated with lower disease severity after adjustment for measured confounders. Individuals vaccinated more than two years before infection may be at risk of more severe disease than those vaccinated more recently.
- 11 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAssociation Between Mpox Vaccination and Disease Severity Over Time in Washington State, 2023-2025
Background: Previous studies suggest that mpox vaccination reduces disease severity among breakthrough infections, but these studies relied on unadjusted comparisons without accounting for confounding by age or health status. We compared disease severity between vaccinated and unvaccinated mpox cases after adjusting for potential confounders. We also evaluated whether time since vaccination was associated with mpox disease severity.Methods: We conducted a retrospective analysis of all confirmed and probable mpox cases reported in Washington State from January 1, 2023 to June 30, 2025, using state surveillance data supplemented by medical record abstraction. Disease severity was measured using an adapted Mpox Severity Scoring System. Individuals were classified as vaccinated if they received at least one dose of the MVA-BN vaccine at least 14 days before symptom onset. Linear regression was used to estimate the associations between vaccination status and disease severity, adjusting for age and immunocompromising conditions. Among vaccinated individuals, we used linear regression to examine associations between time since last vaccine dose (<12 months, 12-<24 months, 24+ months) and disease severity.Findings: Of the 175 reported mpox cases, 164 cases met inclusion criteria; 94 (57%) were vaccinated and 70 (43%) were unvaccinated. The mean mpox severity score among vaccinated individuals was 4·6 (95% CI 4·3-4·9). Vaccination was associated with a 1·44-point lower severity score (0·79-2·09, p<0·001), and with a 1·48-point lower score after adjusting (0·77-2·19, p24 months prior to infection had a 0·97-point higher severity score than those vaccinated within the previous year (0·07-1·87, p=0·035). After adjusting, the difference was 0·93 points (-0·12-1·98, p=0·082).Interpretation: Mpox vaccination was associated with lower disease severity after adjustment for measured confounders. Individuals vaccinated more than two years before infection may be at risk of more severe disease than those vaccinated more recently.
- 19 May 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 101 (9) , 957-963
Evaluating Time-Space Methodologies to Detect Clusters of HIV Transmission: a Comparison of Advanced Methods in Washington State, 2010-2022
Background: Identification of HIV transmission clusters is a key activity under the “Respond” pillar of the United States’ Ending the HIV Epidemic initiative, but the most common method for detecting time-space clusters has low predictive value for future diagnoses in Washington state. We compared different methodologies to the current CDC standard to identify alternative techniques for guiding public health outbreak response locally. Setting: Washington state, 2010-2022 Methods: Using Washington state HIV surveillance data, we applied four methods of detecting anomalies in time series (CDC time-space cluster detection criteria, SaTScan purely temporal, Cumulative Sum [CUSUM], and Log-CUSUM) to the monthly HIV diagnoses at the county level and evaluated predictive ability for increases in diagnoses using micro and macro rate ratios (number of new diagnoses in a region 1 to 12 months after cluster detection relative to a baseline the year before). Results: There were 5,335 new diagnoses in Washington state between 2010 and 2022. The CUSUM method detected 57 clusters and had the highest macro (3.7) and micro (1.7) rate ratios in the month after cluster detection. Over a twelve month period, the log-CUSUM had the highest predictive value (54 clusters, macro 1.7, micro 1.3). Conclusion: The CUSUM methods showed superior ability to identify regions of sustained increases in HIV diagnoses and should be considered for HIV cluster detection and response activities.
- 19 May 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 101 (9) , 957-963
Evaluating Time-Space Methodologies to Detect Clusters of HIV Transmission: a Comparison of Advanced Methods in Washington State, 2010-2022
Background: Identification of HIV transmission clusters is a key activity under the “Respond” pillar of the United States’ Ending the HIV Epidemic initiative, but the most common method for detecting time-space clusters has low predictive value for future diagnoses in Washington state. We compared different methodologies to the current CDC standard to identify alternative techniques for guiding public health outbreak response locally. Setting: Washington state, 2010-2022 Methods: Using Washington state HIV surveillance data, we applied four methods of detecting anomalies in time series (CDC time-space cluster detection criteria, SaTScan purely temporal, Cumulative Sum [CUSUM], and Log-CUSUM) to the monthly HIV diagnoses at the county level and evaluated predictive ability for increases in diagnoses using micro and macro rate ratios (number of new diagnoses in a region 1 to 12 months after cluster detection relative to a baseline the year before). Results: There were 5,335 new diagnoses in Washington state between 2010 and 2022. The CUSUM method detected 57 clusters and had the highest macro (3.7) and micro (1.7) rate ratios in the month after cluster detection. Over a twelve month period, the log-CUSUM had the highest predictive value (54 clusters, macro 1.7, micro 1.3). Conclusion: The CUSUM methods showed superior ability to identify regions of sustained increases in HIV diagnoses and should be considered for HIV cluster detection and response activities.
- 4 May 2026
- Published by BMJ in Sexually Transmitted Infections
Characterising the rate of syphilis diagnosis among people incarcerated in state-level prisons: a cohort study in Washington state 2013–2023
Objective: The syphilis epidemic in the USA has expanded dramatically into new populations, but the overlap with prison populations is unknown. The objective of this analysis was to describe trends in syphilis diagnosis among people incarcerated and released from a state prison system. Methods: This was a cohort study of people released from prison in Washington state between 2010 and 2022. Linking prison rosters to Washington surveillance data, we calculated the rate of syphilis diagnosis between 2013 and 2023 when individuals were inside and outside of prison and compared it to the general population of Washington state. Findings: The rate of syphilis diagnosis increased substantially both in prison (36 per 100 000 person-years in 2013 to 274 in 2022, rate ratio vs general population 1.3 in 2013 to 2.1 in 2023) and out of prison (8 in 2013 to 887 in 2023, rate ratio vs general population 0.3 in 2013 to 6.4 in 2023) over time. Interpretation: From 2013 to 2023, the rate of syphilis diagnosis among those incarcerated in prison in Washington changed from similar to the general population to being significantly greater. Opt-out syphilis testing and treatment in prisons should be included in prison guidelines and accreditation standards.
- 4 May 2026
- Published by BMJ in Sexually Transmitted Infections
Characterising the rate of syphilis diagnosis among people incarcerated in state-level prisons: a cohort study in Washington state 2013–2023
Objective: The syphilis epidemic in the USA has expanded dramatically into new populations, but the overlap with prison populations is unknown. The objective of this analysis was to describe trends in syphilis diagnosis among people incarcerated and released from a state prison system. Methods: This was a cohort study of people released from prison in Washington state between 2010 and 2022. Linking prison rosters to Washington surveillance data, we calculated the rate of syphilis diagnosis between 2013 and 2023 when individuals were inside and outside of prison and compared it to the general population of Washington state. Findings: The rate of syphilis diagnosis increased substantially both in prison (36 per 100 000 person-years in 2013 to 274 in 2022, rate ratio vs general population 1.3 in 2013 to 2.1 in 2023) and out of prison (8 in 2013 to 887 in 2023, rate ratio vs general population 0.3 in 2013 to 6.4 in 2023) over time. Interpretation: From 2013 to 2023, the rate of syphilis diagnosis among those incarcerated in prison in Washington changed from similar to the general population to being significantly greater. Opt-out syphilis testing and treatment in prisons should be included in prison guidelines and accreditation standards.
- Open Access
- 8 August 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 2714
Evaluating the utility of public-facing jail registers to inform public health practice, Washington state 2023
Data on criminal justice system involvement can support public health efforts in ways that have been recognized for decades, but data protections and jurisdictional boundaries can make data sharing difficult. In many jurisdictions, carceral facilities are required to publish lists of currently incarcerated individuals. Automated collection of these lists may be one way for public health to access this information. The purpose of this project was to evaluate the availability, completeness, and utility of carceral data collected from public-facing registers in Washington State. Program staff at the Washington State Department of Health catalogued the websites of all carceral facilities in Washington State and identified what information was available about currently incarcerated individuals. This information was downloaded daily from 1/1/2023 to 12/31/2023 using R software. The completeness of this data was compared relative to the Washington State Jail Booking and Release System (JBRS) during the same time frame. To evaluate the utility of the scraped data (which may contain only partial identifiers) for record linkage, we performed a set of simulated linkages between two external datasets with a known relationship (King County Jail bookings and a surveillance list of people living with HIV who may be out of care). We applied a simple match algorithm to copies of these datasets that had been reduced to match the different combinations of identifier variables available in the public data (full names and ages, partial names, etc.) We compared the sensitivity and positive predictive value (PPV) of the algorithm applied to the reduced datasets and calculated an estimate for the entire dataset weighted by incarcerated population size. At the time of the project, 61 of 71 facilities in Washington State published information about current inmates. 100% of these 61 published names of inmates, 33% age or date of birth, and 13% other identifiers. We collected data from 58 facilities over the project span. 89% of individuals in JBRS were present in the daily scraped data and 95% of individuals in JBRS who were incarcerated for more than 24 h. We estimated that the collected data had 87.7% sensitivity of and 88.8% PPV in linkages with HIV registries. Public facing carceral data in Washington State constitute a data source with high completeness and adequate information for record linkage.
- 8 August 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 2714
Open AccessEvaluating the utility of public-facing jail registers to inform public health practice, Washington state 2023
Data on criminal justice system involvement can support public health efforts in ways that have been recognized for decades, but data protections and jurisdictional boundaries can make data sharing difficult. In many jurisdictions, carceral facilities are required to publish lists of currently incarcerated individuals. Automated collection of these lists may be one way for public health to access this information. The purpose of this project was to evaluate the availability, completeness, and utility of carceral data collected from public-facing registers in Washington State. Program staff at the Washington State Department of Health catalogued the websites of all carceral facilities in Washington State and identified what information was available about currently incarcerated individuals. This information was downloaded daily from 1/1/2023 to 12/31/2023 using R software. The completeness of this data was compared relative to the Washington State Jail Booking and Release System (JBRS) during the same time frame. To evaluate the utility of the scraped data (which may contain only partial identifiers) for record linkage, we performed a set of simulated linkages between two external datasets with a known relationship (King County Jail bookings and a surveillance list of people living with HIV who may be out of care). We applied a simple match algorithm to copies of these datasets that had been reduced to match the different combinations of identifier variables available in the public data (full names and ages, partial names, etc.) We compared the sensitivity and positive predictive value (PPV) of the algorithm applied to the reduced datasets and calculated an estimate for the entire dataset weighted by incarcerated population size. At the time of the project, 61 of 71 facilities in Washington State published information about current inmates. 100% of these 61 published names of inmates, 33% age or date of birth, and 13% other identifiers. We collected data from 58 facilities over the project span. 89% of individuals in JBRS were present in the daily scraped data and 95% of individuals in JBRS who were incarcerated for more than 24 h. We estimated that the collected data had 87.7% sensitivity of and 88.8% PPV in linkages with HIV registries. Public facing carceral data in Washington State constitute a data source with high completeness and adequate information for record linkage.
- 1 March 2025
- Published by American Public Health Association in American Journal of Public Health
- Vol. 115 (3) , 282-286
Real-Time Linkage of Public-Facing Jail Registers and Syphilis Testing and Treatment Monitoring Data, Washington State, 2023–2024
Between June 22, 2023, and January 22, 2024, we implemented scripts to collect public-facing correctional facility rosters and used a matching algorithm to link these data to unresolved syphilis investigations in Washington state. We reviewed the results and sent alerts to the assigned disease intervention specialist. We captured data from 60 of Washington’s 69 correctional facilities and linked 54 individuals to testing or treatment. Fifty-eight percent of individuals had been unlocated for 60 days or more and may not have been found otherwise. ( Am J Public Health. 2025;115(3):282–286. https://doi.org/10.2105/AJPH.2024.307911 )
- 1 March 2025
- Published by American Public Health Association in American Journal of Public Health
- Vol. 115 (3) , 282-286
Real-Time Linkage of Public-Facing Jail Registers and Syphilis Testing and Treatment Monitoring Data, Washington State, 2023–2024
Between June 22, 2023, and January 22, 2024, we implemented scripts to collect public-facing correctional facility rosters and used a matching algorithm to link these data to unresolved syphilis investigations in Washington state. We reviewed the results and sent alerts to the assigned disease intervention specialist. We captured data from 60 of Washington’s 69 correctional facilities and linked 54 individuals to testing or treatment. Fifty-eight percent of individuals had been unlocated for 60 days or more and may not have been found otherwise. ( Am J Public Health. 2025;115(3):282–286. https://doi.org/10.2105/AJPH.2024.307911 )
- 14 June 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (12) , 1840-1847
Development of a rural–urban classification system for public health research that accommodates structural differences between states
Rural environments in the United States present challenges to wellness, but there is a lack of tools with which to categorize rurality at the subcounty level. The most common tool, the Food and Drug Administration’s 2010 Rural–Urban Commuting Area (RUCA) codes, uses data that are over a decade old and cannot accommodate regional differences in rurality. The purpose of this study was to develop a census-tract classification system of rurality and demonstrate its use in describing HIV outcomes. We transformed census-tract measures (population density, natural resource workforce, walkability index, household type, and air quality) into local scales of rurality using factor analysis. We surveyed public health practitioners to determine cutpoints and compared the resulting categorization with RUCA codes. We characterized the incidence of HIV in Washington State according to rurality category. Our classification system categorized 25% of census tracts as rural, 19% as periurban, and 56% as urban. Our survey yielded cutoffs that were more conservative in categorizing urban areas than RUCA codes. The rate of HIV diagnosis was substantially higher in urban areas. Our rural–urban classification system offers an alternative to RUCA codes that is more responsive to regional differences.
- 14 June 2024
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (12) , 1840-1847
Development of a rural–urban classification system for public health research that accommodates structural differences between states
Rural environments in the United States present challenges to wellness, but there is a lack of tools with which to categorize rurality at the subcounty level. The most common tool, the Food and Drug Administration’s 2010 Rural–Urban Commuting Area (RUCA) codes, uses data that are over a decade old and cannot accommodate regional differences in rurality. The purpose of this study was to develop a census-tract classification system of rurality and demonstrate its use in describing HIV outcomes. We transformed census-tract measures (population density, natural resource workforce, walkability index, household type, and air quality) into local scales of rurality using factor analysis. We surveyed public health practitioners to determine cutpoints and compared the resulting categorization with RUCA codes. We characterized the incidence of HIV in Washington State according to rurality category. Our classification system categorized 25% of census tracts as rural, 19% as periurban, and 56% as urban. Our survey yielded cutoffs that were more conservative in categorizing urban areas than RUCA codes. The rate of HIV diagnosis was substantially higher in urban areas. Our rural–urban classification system offers an alternative to RUCA codes that is more responsive to regional differences.
- 1 June 2024
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 96 (2) , 106-113
Impact of COVID-19 on People Living With HIV: Data From Five Medical Monitoring Project Sites, 2020–2022
Background: The COVID-19 pandemic disrupted global economic and healthcare systems. People living with HIV (PLWH) represent a marginalized and stigmatized population who may have been particularly impacted. The purpose of this analysis was to describe the impact of the COVID-19 pandemic on PLWH in the United States. Setting: United States. Methods: We analyzed surveys of behavioral and clinical characteristics of PLWH residing in 5 states that participated in the Medical Monitoring Project between 2020 and 2022. We described the impact of COVID-19 illness, testing, and diagnoses; receipt of medical care; social service access; employment; and preventive measures by project site and demographic characteristics. Results: Unweighted data from 1715 PLWH were analyzed. A high proportion of PLWH had medical care disrupted by the pandemic; 31% of PLWH missed medical appointments, 26% missed routine laboratory test results, and 7% missed antiretroviral therapy doses. In total, 30% of PLWH reported losing wages and 19% reported difficulty in accessing social services. Overall, 88% reported receiving at least 1 dose of COVID-19 vaccine, but vaccine uptake was low among younger, Black, and Hispanic or Latina/o/x PLWH. Conclusions: This descriptive analysis reinforces previous findings that show that COVID-19 negatively impacted PLWH and their ability to obtain medical care. Additional efforts will be critical to ameliorating the longer-term impacts of COVID-19 on the health of PLWH and supporting PLWH through future pandemics and healthcare system disruptions.
- 1 June 2024
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 96 (2) , 106-113
Impact of COVID-19 on People Living With HIV: Data From Five Medical Monitoring Project Sites, 2020–2022
Background: The COVID-19 pandemic disrupted global economic and healthcare systems. People living with HIV (PLWH) represent a marginalized and stigmatized population who may have been particularly impacted. The purpose of this analysis was to describe the impact of the COVID-19 pandemic on PLWH in the United States. Setting: United States. Methods: We analyzed surveys of behavioral and clinical characteristics of PLWH residing in 5 states that participated in the Medical Monitoring Project between 2020 and 2022. We described the impact of COVID-19 illness, testing, and diagnoses; receipt of medical care; social service access; employment; and preventive measures by project site and demographic characteristics. Results: Unweighted data from 1715 PLWH were analyzed. A high proportion of PLWH had medical care disrupted by the pandemic; 31% of PLWH missed medical appointments, 26% missed routine laboratory test results, and 7% missed antiretroviral therapy doses. In total, 30% of PLWH reported losing wages and 19% reported difficulty in accessing social services. Overall, 88% reported receiving at least 1 dose of COVID-19 vaccine, but vaccine uptake was low among younger, Black, and Hispanic or Latina/o/x PLWH. Conclusions: This descriptive analysis reinforces previous findings that show that COVID-19 negatively impacted PLWH and their ability to obtain medical care. Additional efforts will be critical to ameliorating the longer-term impacts of COVID-19 on the health of PLWH and supporting PLWH through future pandemics and healthcare system disruptions.
- 8 February 2024
- Published by SAGE Publications in Public Health Reports®
- Vol. 139 (5) , 573-581
Cost Analysis of Implementing a 12-Month Recertification Criterion for Ryan White HIV/AIDS Program’s AIDS Drug Assistance Program in Washington State
Objective: AIDS Drug Assistance Programs (ADAPs) are state-administered programs that pay for medical care and medication for people living with HIV (PLWH) in the United States. In October 2021, the federal policy requiring that clients recertify for the program every 6 months was repealed, giving states the authority to set their own recertification policies. However, little data exist on the costs and health effects of alternative recertification schedules. We assessed the cost of changing the legacy 6-month recertification to a 12-month schedule in Washington State to inform policy decisions on recertification. Methods: We used a Markov model to simulate the population of PLWH in Washington State who are eligible or enrolled in ADAP. We obtained model inputs and validation data from the Washington State Ryan White database. We estimated the cost of 12-month and 6-month criteria over a 5-year time horizon. Model outputs included annual program costs, population sizes, and number of people virally suppressed, by scenario. Results: Under a continuation of the legacy 6-month recertification criteria, the annual cost of Washington ADAP would be $37 663 000 (95% CI, $34 570 000-$41 686 000) during the next 5 years, with a per-client cost of $7966 (95% CI, $7478-$8494). Under 12-month criteria, the annual cost would be $40 217 000 (95% CI, $36 243 000-$44 401 000) and the per-client cost would be $7543 (95% CI, $7084-$8042). Under the 12-month scenario, 245 more people will have been virally suppressed by the end of 2025. Conclusions: Switching to a less frequent recertification process may improve health outcomes at a modest increase in cost in Washington State.
- 8 February 2024
- Published by SAGE Publications in Public Health Reports®
- Vol. 139 (5) , 573-581
Cost Analysis of Implementing a 12-Month Recertification Criterion for Ryan White HIV/AIDS Program’s AIDS Drug Assistance Program in Washington State
Objective: AIDS Drug Assistance Programs (ADAPs) are state-administered programs that pay for medical care and medication for people living with HIV (PLWH) in the United States. In October 2021, the federal policy requiring that clients recertify for the program every 6 months was repealed, giving states the authority to set their own recertification policies. However, little data exist on the costs and health effects of alternative recertification schedules. We assessed the cost of changing the legacy 6-month recertification to a 12-month schedule in Washington State to inform policy decisions on recertification. Methods: We used a Markov model to simulate the population of PLWH in Washington State who are eligible or enrolled in ADAP. We obtained model inputs and validation data from the Washington State Ryan White database. We estimated the cost of 12-month and 6-month criteria over a 5-year time horizon. Model outputs included annual program costs, population sizes, and number of people virally suppressed, by scenario. Results: Under a continuation of the legacy 6-month recertification criteria, the annual cost of Washington ADAP would be $37 663 000 (95% CI, $34 570 000-$41 686 000) during the next 5 years, with a per-client cost of $7966 (95% CI, $7478-$8494). Under 12-month criteria, the annual cost would be $40 217 000 (95% CI, $36 243 000-$44 401 000) and the per-client cost would be $7543 (95% CI, $7084-$8042). Under the 12-month scenario, 245 more people will have been virally suppressed by the end of 2025. Conclusions: Switching to a less frequent recertification process may improve health outcomes at a modest increase in cost in Washington State.